In addition to our core partnership models, Sinapse offers a suite of complementary services designed to bridge the gap between AI concepts and real-world clinical impact. We don’t just provide software; we provide the expertise needed to navigate the complex journey of medical innovation with a focus on real, evidence-based impact.
We guide projects from the initial idea to a market-ready product, ensuring every stage of development is rigorous and scalable.
Our strength lies in our people – a dedicated team combining expertise in medicine, artificial intelligence, and business strategy;
We leverage established scientific platforms, including direct access to hospital environments, university resources and access to clinical studies through collaboration with scientific partners.
From concept validation to scalable product development, we design pilot programs and conduct real-world testing in collaboration with our clinical, academic, and industry partners.
We provide comprehensive market analysis and go-to-market planning to transform medical innovations into scalable value. From business model design to partnership strategies, we ensure your solution is positioned for commercial success and long-term growth.
We build robust data quality frameworks and governance models that prioritize privacy and security. By designing scalable data architectures, we ensure your AI solutions are not only reliable but fully compliant with stringent medical standards.
We provide expert guidance through the complexities of the medical landscape, focusing on regulatory pathways and market access. Our team develops tailored reimbursement strategies and ensures your innovation meets all healthcare system requirements for clinical adoption across the EU.
We provide workshops and trainings to strengthen your team’s internal capabilities and deliver specialized knowledge. Our programs cover AI data modeling and health-tech innovation, providing the team enablement required to lead in the digital health space.
We support the expansion of your clinical impact through industrial research, experimental development, and strategic scaling. From international market entry to ROI modeling, we ensure your organization is prepared for the transition from pilot projects to a global presence.
SIA “AKA Sinapse’’
Registration No.: 40203500743
VAT No.: LV40203500743
Legal Address: Īvandes St. 5, Riga, LV-1004, Latvia
Bank: AS SWEDBANK
SWIFT: HABALV22
IBAN: LV29 HABA 0551 0549 8549 7
